Record NNP B-NP O
date NN I-NP O
: : O O
2109-09-14 CD O B-DATE
September NNP B-NP B-DATE
14 CD I-NP I-DATE
, , I-NP I-DATE
2109 CD O I-DATE
Vicente NNP B-NP B-DOCTOR
Blair NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
Internal NNP B-NP O
Medical NNP I-NP O
Doctors NNS B-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
North NNP I-NP I-HOSPITAL
Omak NNP B-NP B-CITY
, , O O
Georgia NNP B-NP B-STATE
72196 CD I-NP B-ZIP
RE RB B-ADVP O
: : O O
VALDEZ NN B-NP I-PATIENT
, , O I-PATIENT
Harlan NNP B-NP I-PATIENT
DHN NNP B-NP B-HOSPITAL
# # I-NP O
: : O O
7672624 CD O B-MEDICALRECORD
DATE NNP B-NP O
OF IN B-PP O
BIRTH NNP B-NP O
: : O O
11/09/2062 CD O B-DATE
CURRENT NNP B-NP O
CLINIC NN I-NP O
VISIT NNP I-NP O
DATE NNP I-NP O
: : O O
09/14/2109 CD O B-DATE
Dear NNP B-NP O
Vicente NNP I-NP B-DOCTOR
, , O O
Thank VB B-VP O
you PRP B-NP O
in IN B-PP O
advance NN B-NP O
for IN B-PP O
allowing VBG B-VP O
me PRP B-NP O
to TO B-VP O
share VB I-VP O
in IN B-PP O
the DT B-NP O
medical JJ I-NP O
care NN I-NP O
of IN B-PP O
Mr. NNP B-NP O
Harlan NNP I-NP B-PATIENT
B. NNP I-NP I-PATIENT
Valdez NNP I-NP I-PATIENT
, , O O
a DT B-NP O
46 CD I-NP B-AGE
-year-old JJ I-NP O
male JJ I-NP O
patient NN I-NP O
with IN B-PP O
prior JJ B-NP O
polysomnographic JJ I-NP O
evidence NN I-NP O
of IN B-PP O
sleep NN B-NP O
disordered JJ I-NP O
breathing NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
difficulty NN B-NP O
in IN B-PP O
sleep NN B-NP O
, , I-NP O
reinitiation NN I-NP O
and CC I-NP O
maintenance NN I-NP O
and CC O O
increased VBD B-VP O
early JJ B-NP O
morning NN I-NP O
awakenings NNS I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
mixed JJ B-NP O
systemic JJ I-NP O
medical JJ I-NP O
conditions NNS I-NP O
. . O O
HISTORY NN B-NP O
OF IN B-PP O
PRESENT JJ B-NP O
ILLNESS NNS I-NP O
: : O O
As IN B-SBAR O
you PRP B-NP O
already RB B-ADVP O
know VBP B-VP O
, , O O
Mr. NNP B-NP O
Valdez NNP I-NP B-PATIENT
who WP B-NP O
demonstrates VBZ B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
difficulties NNS B-NP O
of IN B-PP O
sleep NN B-NP O
reinitiation NN I-NP O
and CC I-NP O
maintenance NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
increased VBN B-NP O
early JJ I-NP O
morning NN I-NP O
awakenings NNS I-NP O
, , O O
has VBZ B-VP O
noted VBN I-VP O
an DT B-NP O
exacerbation NN I-NP O
of IN B-PP O
these DT B-NP O
sleep NN I-NP O
difficulties NNS I-NP O
, , O O
occurring VBG B-VP O
in IN B-PP O
temporal JJ B-NP O
association NN I-NP O
with IN B-PP O
his PRP$ B-NP O
loss NN I-NP O
of IN B-PP O
his PRP$ B-NP O
wife NN I-NP O
from IN B-PP O
pancreatic JJ B-NP O
cancer NN I-NP O
last JJ B-NP O
year NN I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
now RB I-VP O
placed VBN I-VP O
in IN B-PP O
the DT B-NP O
unfortunate JJ I-NP O
situation NN I-NP O
of IN B-PP O
being VBG B-VP O
a DT B-NP O
single JJ I-NP O
parent NN I-NP O
to TO B-PP O
a DT B-NP O
15 CD I-NP B-AGE
-year-old JJ I-NP O
son NN I-NP O
and CC O O
a DT B-NP O
10 CD I-NP B-AGE
-year-old JJ I-NP O
daughter NN I-NP O
and CC O O
describes VBZ B-VP O
a DT B-NP O
modification NN I-NP O
of IN B-PP O
his PRP$ B-NP O
current JJ I-NP O
employment NN I-NP O
duties NNS I-NP O
of IN B-PP O
a DT B-NP O
set NN I-NP B-PROFESSION
designer NN I-NP I-PROFESSION
. . O O
In IN B-PP O
particular JJ B-NP O
, , O O
Mr. NNP B-NP O
Valdez NNP I-NP B-PATIENT
describes VBZ B-VP O
undergoing VBG I-VP O
on IN B-PP O
frequent JJ B-NP O
international JJ I-NP O
travelling NN I-NP O
which WDT B-NP O
has VBZ B-VP O
bee NN B-NP O
markedly RB B-ADJP O
curtailed VBN I-ADJP O
as IN B-SBAR O
he PRP B-NP O
is VBZ B-VP O
tending VBG I-VP O
to TO B-PP O
his PRP$ B-NP O
family NN I-NP O
situation NN I-NP O
closer JJR B-ADJP O
to TO B-PP O
home NN B-NP O
. . O O
He PRP B-NP O
described VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
intermittent JJ B-NP O
snoring NN I-NP O
symptomatology NN I-NP O
but CC O O
is VBZ B-VP O
unaware JJ B-ADJP O
of IN B-PP O
specific JJ B-NP O
nocturnal JJ I-NP O
respiratory JJ I-NP O
pauses NNS I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
unaware JJ B-ADJP O
of IN B-PP O
a DT B-NP O
"restless JJ I-NP O
" `` I-NP O
lower JJR I-NP O
limb NN I-NP O
sensory JJ I-NP O
complaints NNS I-NP O
which WDT B-NP O
may MD B-VP O
impact VB I-VP O
on IN B-PP O
his PRP$ B-NP O
ability NN I-NP O
to TO B-VP O
initiate VB I-VP O
or CC I-VP O
reinitiate VB I-VP O
sleep. JJR B-NP O
He PRP B-NP O
denies VBZ B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
a DT B-NP O
" `` I-NP O
night NN I-NP O
owl NN I-NP O
" `` I-NP O
personality NN I-NP O
or CC I-NP O
circadian JJ I-NP O
rhythm NN I-NP O
dysfunction NN I-NP O
which WDT B-NP O
may MD B-VP O
have VB I-VP O
played VBN I-VP O
a DT B-NP O
role NN I-NP O
with IN B-PP O
respect NN B-NP O
to TO B-PP O
nocturnal JJ B-NP O
sleep NN I-NP O
disruptions NNS I-NP O
or CC O O
sleep NN B-NP O
difficulties NNS I-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
paroxysmal JJ B-NP O
abnormal JJ I-NP O
disturbances NNS I-NP O
or CC O O
associated VBN B-VP O
narcoleptic JJ B-NP O
symptoms NNS I-NP O
. . O O
Mr. NNP B-NP O
Valdez NNP I-NP B-PATIENT
underwent IN B-PP O
an DT B-NP O
initial JJ I-NP O
formal JJ I-NP O
polysomnographic JJ I-NP O
evaluation NN I-NP O
at IN B-PP O
the DT B-NP O
center NN I-NP O
for IN B-PP O
sleep NN B-NP O
diagnostics NNS I-NP O
at IN B-PP O
Holy NNP B-NP B-HOSPITAL
Cross NNP I-NP I-HOSPITAL
on IN B-PP O
11/26/05 CD B-NP B-DATE
, , O O
during IN B-PP O
which WDT B-NP O
time NN B-NP O
he PRP B-NP O
was VBD B-VP O
noted VBN I-VP O
to TO I-VP O
demonstrate VB I-VP O
a DT B-NP O
respiratory JJ I-NP O
disturbance NN I-NP O
index NN I-NP O
of IN B-PP O
81/hour CD B-NP O
, , O O
particularly RB B-VP O
exacerbated VBN I-VP O
in IN B-PP O
the DT B-NP O
supine NN I-NP O
position NN I-NP O
and CC O O
characterized VBD B-VP O
predominantly RB B-ADVP O
by IN B-PP O
hypopneas NNS B-NP O
, , O O
with IN B-PP O
equal JJ B-NP O
distribution NN I-NP O
during IN B-PP O
non-REM JJ B-NP O
and CC I-NP O
stage NN I-NP O
REM JJ I-NP O
sleep NN I-NP O
and CC B-PP O
with IN B-PP O
associated JJ B-NP O
O2 JJ I-NP O
desaturation NN I-NP O
Nadir NNP B-NP O
of IN B-PP O
88 CD B-NP O
% NN I-NP O
The DT B-NP O
respiratory NN I-NP O
disturbances NNS I-NP O
were VBD B-VP O
predominantly RB B-ADJP O
obstructive JJ I-ADJP O
or CC O O
mixed JJ B-NP O
hypopneas NNS I-NP O
. . O O
In IN B-PP O
addition NN B-NP O
, , O O
loud JJ B-NP O
snoring NN I-NP O
was VBD B-VP O
noted VBN I-VP O
. . O O
There EX B-NP O
was VBD B-VP O
evidence NN B-NP O
of IN B-PP O
a DT B-NP O
sleep NN I-NP O
efficiency NN I-NP O
of IN B-PP O
88 CD B-NP O
% NN I-NP O
and CC O O
a DT B-NP O
short JJ I-NP O
sleep NN I-NP O
onset IN B-PP O
latency RB B-NP O
of IN I-NP O
4 CD I-NP O
minutes NNS I-NP O
. . O O
There EX B-NP O
was VBD B-VP O
a DT B-NP O
predominance NN I-NP O
of IN B-PP O
"light JJ B-NP O
" `` I-NP O
non-REM JJ I-NP O
stages NNS I-NP O
I-II JJ B-NP O
sleep NN I-NP O
, , O O
and CC O O
a DT B-NP O
concomitant NN I-NP O
inability NN I-NP O
to TO B-VP O
achieve VB I-VP O
significant JJ B-NP O
" `` I-NP O
slow-wave JJ I-NP O
" '' I-NP O
or CC I-NP O
stage NN I-NP O
REM NNS I-NP O
sleep. VBD B-VP O
There EX B-NP O
was VBD B-VP O
also RB B-ADVP O
"alpha DT B-NP O
intrusions NNS I-NP O
and CC I-NP O
alpha NN I-NP O
delta NN I-NP O
sleep" NN I-NP O
evident JJ B-ADJP O
during IN B-PP O
the DT B-NP O
initial JJ I-NP O
sleep NN I-NP O
study NN I-NP O
. . O O
In IN B-PP O
addition NN B-NP O
premature JJ B-NP O
ventricular JJ I-NP O
contractions NNS I-NP O
were VBD B-VP O
noted VBN I-VP O
. . O O
The DT B-NP O
patient NN I-NP O
underwent IN B-PP O
a DT B-NP O
CPAP NNP I-NP O
titration NN I-NP O
on IN B-PP O
01/15/06 CD B-NP B-DATE
, , O O
also RB B-ADVP O
at IN B-PP O
the DT B-NP O
Tenacre NNP I-NP B-HOSPITAL
Foundation NNP I-NP I-HOSPITAL
Nursing NNP I-NP I-HOSPITAL
Home NNP I-NP I-HOSPITAL
in IN B-PP O
Boxborough NNP B-NP B-CITY
, , O O
during IN B-PP O
which WDT B-NP O
time NN B-NP O
there EX B-NP O
was VBD B-VP O
a DT B-NP O
marked VBN I-NP O
reduction NN I-NP O
in IN B-PP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
hypopneas NNS B-NP O
( -LRB- I-NP O
respiratory NN I-NP O
disturbance NN I-NP O
index NN I-NP O
equals NNS I-NP O
2/hour VBD B-VP O
) -RRB- B-NP O
with IN B-PP O
CPAP NNP B-NP O
titrations NNS I-NP O
between IN B-PP O
4-6 CD B-NP O
cm NN I-NP O
. . O O
Sleep VB B-VP O
efficiency NN B-NP O
improved VBN B-VP O
to TO B-PP O
91 CD B-NP O
% NN I-NP O
, , O O
a DT B-NP O
short JJ I-NP O
sleep NN I-NP O
onset NN I-NP O
latency RB B-ADVP O
was VBD B-VP O
also RB I-VP O
noted VBN I-VP O
( -LRB- B-NP O
3 CD I-NP O
minutes NNS I-NP O
) -RRB- B-ADVP O
. . O O
There EX B-NP O
was VBD B-VP O
once RB O O
again RB B-ADVP O
an DT B-NP O
increased VBN I-NP O
predominance NN I-NP O
of IN B-PP O
"light JJ B-NP O
" `` I-NP O
non-REM JJ I-NP O
stage NN I-NP O
I-II JJ I-NP O
sleep NN I-NP O
, , O O
with IN B-PP O
concomitant JJ B-NP O
inability NN I-NP O
to TO B-VP O
achieve VB I-VP O
sustained VBN I-VP O
" `` O O
slow JJ B-NP O
wave NN I-NP O
sleep" NN I-NP O
. . O O
Since IN B-PP O
his PRP$ B-NP O
initial JJ I-NP O
trial NN I-NP O
of IN B-PP O
nocturnal JJ B-NP O
CPAP NNP I-NP O
titration NN I-NP O
( -LRB- I-NP O
at IN B-PP O
6 CD B-NP O
cm NN I-NP O
of IN B-PP O
water NN B-NP O
pressure NN I-NP O
) -RRB- I-NP O
and CC B-PP O
with IN B-PP O
various JJ B-NP O
CPAP NNP I-NP O
mask NN I-NP O
modifications NNS I-NP O
( -LRB- O O
including VBG B-PP O
CPAP NNP B-NP O
nasal JJ I-NP O
face NN I-NP O
mask NN I-NP O
and CC O O
a DT B-NP O
Mallinckrodt NNP I-NP O
" `` I-NP O
Breeze NNP I-NP O
" '' I-NP O
supportive JJ I-NP O
head NN I-NP O
gear NN I-NP O
with IN B-PP O
"nasal NN B-NP O
pillows NNS I-NP O
" '' O O
. . O O
The DT B-NP O
patient NN I-NP O
describes VBZ B-VP O
associated VBN I-VP O
claustrophobic JJ B-NP O
symptomatology NN I-NP O
, , O O
relative JJ B-NP O
difficulties NNS I-NP O
with IN B-PP O
sustained JJ B-NP O
nocturnal JJ I-NP O
home NN I-NP O
CPAP NNS I-NP O
use VBP B-VP O
, , O O
and CC O O
difficulties NNS B-NP O
with IN B-PP O
regards NNS B-NP O
to TO B-PP O
CPAP NNP B-NP O
to TO B-PP O
being VBG B-NP O
and CC I-NP O
complications NNS I-NP O
by IN B-PP O
the DT B-NP O
bulkiness NN I-NP O
of IN B-PP O
the DT B-NP O
CPAP NNP I-NP O
machine NN I-NP O
in IN B-PP O
general JJ B-ADJP O
. . O O
As IN B-PP O
a DT B-NP O
result NN I-NP O
, , O O
he PRP B-NP O
has VBZ B-VP O
not RB I-VP O
utilized VBN I-VP O
nocturnal JJ B-NP O
CPAP NNP I-NP O
therapy NN I-NP O
for IN B-PP O
a DT B-NP O
period NN I-NP O
of IN B-PP O
time NN B-NP O
, , O O
although IN B-SBAR O
he PRP B-NP O
still RB B-ADVP O
maintains VBZ B-VP O
the DT B-NP O
CPAP NNP I-NP O
equipment NN I-NP O
in IN B-PP O
his PRP$ B-NP O
house NN I-NP O
. . O O
Of IN B-PP O
particular JJ B-NP O
note NN I-NP O
, , O O
and CC O O
exacerbation NN B-NP O
of IN B-PP O
the DT B-NP O
past JJ I-NP O
year NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
demonstrates VBZ B-VP O
increased VBN I-VP O
early JJ B-NP O
morning NN I-NP O
awakenings NNS I-NP O
(averaging VBG B-VP O
2-4 CD B-NP O
in IN B-PP O
number NN B-NP O
) -RRB- I-NP O
with IN B-PP O
typical JJ B-NP O
awakenings NNS I-NP O
occurring VBG B-VP O
approximately RB B-NP O
two CD I-NP O
hours NNS I-NP O
after IN B-PP O
sleep NN B-NP O
initiation NN I-NP O
at IN B-PP O
9:30 CD B-NP O
p.m. NN I-NP O
( -LRB- O O
the DT B-NP O
patient NN I-NP O
describes VBZ B-VP O
one CD B-NP O
awakening VBG B-VP O
at IN B-PP O
11:30 CD B-NP O
p.m. RB I-NP O
and CC O O
the DT B-NP O
second JJ I-NP O
awakening NN I-NP O
at IN B-PP O
11:45 CD B-NP O
a.m. RB I-NP O
, , O O
of IN B-PP O
unclear JJ B-NP O
causative JJ I-NP O
etiology NN I-NP O
) -RRB- I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
then RB B-ADVP O
might MD B-VP O
awaken VB I-VP O
at IN B-PP O
3 CD B-NP O
a.m. NN I-NP O
and CC O O
be VB B-VP O
"ready JJ B-ADJP O
for IN B-PP O
the DT B-NP O
day" NN I-NP O
. . O O
If IN B-SBAR O
he PRP B-NP O
is VBZ B-VP O
able JJ B-ADJP O
to TO B-VP O
reinitiate VB I-VP O
sleep NN B-NP O
thereafter RB B-ADVP O
, , O O
the DT B-NP O
patient NN I-NP O
may MD B-VP O
demonstrate VB I-VP O
additional JJ B-NP O
two CD I-NP O
early JJ I-NP O
morning NN I-NP O
awakenings NNS I-NP O
after IN B-PP O
a DT B-NP O
final JJ I-NP O
awakening NN I-NP O
at IN B-PP O
6 CD B-NP O
a.m. RB I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ B-VP O
noted VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
mixed JJ B-NP O
systemic JJ I-NP O
conditions NNS I-NP O
including VBG I-NP O
diabetes NNS I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
depressive JJ B-NP O
disorder NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
a DT B-NP O
relatively RB I-NP O
stable JJ I-NP O
gastrointestinal JJ I-NP O
condition NN I-NP O
, , O O
with IN B-PP O
no DT B-NP O
upper JJ I-NP O
GI JJ I-NP O
evidence NN I-NP O
of IN B-PP O
gastroparesis NN B-NP O
. . O O
MEDICATIONS NNS B-NP O
: : O O
1 CD B-NP O
. . O O
Provigil NNP O O
200 CD B-NP O
mg NN I-NP O
p.o NN I-NP O
. . B-NP O
q NN I-NP O
. . O O
a.m. RB B-ADVP O
PRN. . O O
2. DT B-NP O
Lithium NNP I-NP O
. . O O
3. DT B-NP O
Valproate NNP I-NP O
. . O O
4 CD B-LST O
. . O O
Glucophage NNP B-NP O
850 CD I-NP O
mg NN I-NP O
t.i.d NN I-NP O
. . O O
5 CD B-NP O
. . O O
Humulin NNP B-NP O
15 CD I-NP O
units NNS I-NP O
at IN B-PP O
night NN B-NP O
. . O O
6 CD B-NP O
. . O O
Folate NNP B-NP O
. . O O
7. CD B-NP O
Metoprolol NNP I-NP O
. . O O
8. DT B-NP O
Cardia NNP I-NP O
. . O O
9 CD B-NP O
. . O O
Vitamin NNP B-NP O
E. NNP I-NP O
10 CD B-NP O
. . I-NP O
Coated NNP I-NP O
aspirin NN I-NP O
. . O O
ALLERGIES/ADVERS NNP B-NP O
E NNP I-NP O
REACTIONS NNP I-NP O
: : O O
The DT B-NP O
patient NN I-NP O
describes VBZ B-VP O
an DT B-NP O
enhancement NN I-NP O
to TO B-PP O
suicidal JJ B-NP O
tendencies NNS I-NP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
prior JJ B-NP O
Prozac NNP I-NP O
usage NN I-NP O
. . O O
SOCIAL JJ B-NP O
HISTORY NN I-NP O
: : O O
The DT B-NP O
patient NN I-NP O
denies VBZ B-VP O
active JJ B-NP O
tobacco NN I-NP O
or CC I-NP O
alcoholic JJ I-NP O
beverage NN I-NP O
usage NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
lost VBN I-VP O
15-20 CD B-NP O
pounds NNS I-NP O
over IN B-PP O
the DT B-NP O
past JJ I-NP O
several JJ I-NP O
years NNS I-NP O
. . O O
His PRP$ B-NP O
current JJ I-NP O
weight NN I-NP O
is VBZ B-VP O
195 CD B-NP O
pounds NNS I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
desirous JJ B-ADJP O
of IN B-PP O
losing VBG B-VP O
some DT B-NP O
additional JJ I-NP O
weight NN I-NP O
with IN B-PP O
regards NNS B-NP O
to TO B-VP O
more RBR B-NP O
regular JJ I-NP O
exercise NN I-NP O
, , O O
but CC O O
his PRP$ B-NP O
hectic JJ I-NP O
social JJ I-NP O
situation NN I-NP O
makes VBZ B-VP O
this DT B-NP O
somewhat RB I-NP O
difficult JJ I-NP O
at IN B-PP O
the DT B-NP O
present JJ I-NP O
time NN I-NP O
. . O O
On IN B-PP O
examination NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
demonstrates VBZ B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-PP O
146/88 CD B-NP O
, , O O
( -LRB- B-VP O
seated VBN I-VP O
, , O O
left JJ B-NP O
arm NN I-NP O
) -RRB- I-NP O
, , I-NP O
respiratory JJ I-NP O
rate NN I-NP O
16 CD I-NP O
. . O O
HEENT NNP B-NP O
EXAMINATION NNP I-NP O
: : O O
Borderline NNP B-NP O
small JJ I-NP O
posterior JJ I-NP O
oropharyngeal JJ I-NP O
aperture NN I-NP O
, , O O
with IN B-PP O
slightly RB B-NP O
increased VBN I-NP O
redundant JJ I-NP O
tissue NN I-NP O
evident JJ I-NP O
posteriorly RB B-ADVP O
and CC O O
a DT B-NP O
slightly RB I-NP O
elongated VBN I-NP O
uvula NNP I-NP O
noted VBD B-VP O
. . O O
The DT B-NP O
patient NN I-NP O
appears VBZ B-VP O
awake RB B-ADVP O
, , O O
alert JJ B-ADVP O
, , O O
with IN B-PP O
speech NN B-NP O
clear JJ I-NP O
and CC I-NP O
fluent JJ I-NP O
and CC I-NP O
receptive JJ I-NP O
language NN I-NP O
function NN I-NP O
essentially RB B-ADJP O
intact JJ I-ADJP O
. . O O
He PRP B-NP O
is VBZ B-VP O
presently RB I-VP O
wearing VBG I-VP O
dental JJ B-NP O
braces NNS I-NP O
. . O O
No DT B-NP O
obvious JJ I-NP O
cranial JJ I-NP O
nerve NN I-NP O
deficits NNS I-NP O
are VBP B-VP O
appreciated VBN I-VP O
. . O O
No DT B-NP O
focal JJ I-NP O
, , I-NP O
sensory JJ I-NP O
, , I-NP O
motor NN I-NP O
or CC I-NP O
neurologic NN I-NP O
deficits NNS I-NP O
are VBP B-VP O
noted VBN I-VP O
. . O O
No DT B-NP O
significant JJ I-NP O
appendicular JJ I-NP O
dystaxias NNS I-NP O
or CC I-NP O
dysmetrias NNS I-NP O
are VBP B-VP O
currently RB B-ADVP O
in IN B-PP O
evidence NN B-NP O
. . O O
The DT B-NP O
routine NN I-NP O
gait NN I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
normal JJ B-ADJP O
based VBN B-NP O
, , O O
without IN B-PP O
evidence NN B-NP O
of IN B-PP O
significant JJ B-NP O
gait NN I-NP O
dystaxias NNS I-NP O
. . O O
No DT B-NP O
current JJ I-NP O
clinical JJ I-NP O
ictal JJ I-NP O
manifestations NNS I-NP O
are VBP B-VP O
present JJ B-ADJP O
. . O O
No DT B-NP O
acute JJ I-NP O
evidence NN I-NP O
of IN B-PP O
"micro-sleeps NNS B-NP O
" `` O O
are VBP B-VP O
noted VBN I-VP O
. . O O
IMPRESSION NN B-NP O
: : O O
1 LS O O
. . O O
Sleep VB B-VP O
stage/arrousal JJ B-NP O
dysfunction NN I-NP O
( -LRB- I-NP O
780.56 CD I-NP O
) -RRB- I-NP O
: : O O
Manifested JJ B-ADJP O
by IN B-PP O
subjective JJ B-NP O
complaints NNS I-NP O
of IN B-PP O
nonrestorative JJ B-NP O
sleep NN I-NP O
, , O O
increased VBD B-VP O
daytime JJ B-NP O
fatigue NN I-NP O
and CC O O
alternating VBG B-VP O
hypersomnia NN B-NP O
, , O O
and CC O O
recurrent JJ B-NP O
polysomnographic JJ I-NP O
evidence NN I-NP O
of IN B-PP O
"lightened VBN B-NP O
" '' O O
sleep VB B-VP O
pattern NN B-NP O
, , O O
with IN B-PP O
increased VBN B-NP O
predominance NN I-NP O
of IN B-PP O
non-REM JJ B-NP O
stages NNS I-NP O
1-2 JJ B-NP O
sleep NN I-NP O
, , O O
and CC O O
with IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
"alpha" JJ B-NP O
intrusions NNS I-NP O
and CC O O
"alpha JJ B-NP O
delta NN I-NP O
" '' I-NP O
component NN I-NP O
to TO B-PP O
deeper JJR B-NP O
sleep. VBG I-NP O
These DT B-NP O
latter JJ I-NP O
EEG NNP I-NP O
findings NNS I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
subjective JJ B-NP O
complaints NNS I-NP O
of IN B-PP O
nonrestorative JJ B-NP O
sleep NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
clinical JJ B-NP O
setting NN I-NP O
of IN B-PP O
chronic JJ B-NP O
pain NN I-NP O
related VBN I-NP O
complaints NNS I-NP O
, , O O
depressive JJ B-ADJP O
or CC O O
anxiety NN B-NP O
disorder NN I-NP O
or CC I-NP O
intercurrent NN I-NP O
psychotropics NNS I-NP O
agents NNS I-NP O
used VBN B-VP O
( -LRB- B-ADVP O
but CC I-ADVP O
more RBR I-ADVP O
usually RB I-ADVP O
associated VBN B-VP O
with IN B-PP O
benzodiazepine NN B-NP O
or CC O O
barbituate JJ B-NP O
usage NN I-NP O
) -RRB- I-NP O
. . O O
2. DT B-NP O
Sleep NN I-NP O
disordered VBD B-VP O
breathing NN B-NP O
: : O O
As IN B-SBAR O
evidenced VBN B-VP O
during IN B-PP O
prior JJ B-NP O
polysomnographic JJ I-NP O
evaluations NNS I-NP O
, , O O
mostly RB B-PP O
of IN I-PP O
obstructive JJ B-NP O
and CC I-NP O
or CC I-NP O
mixed JJ I-NP O
hypopnea NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
appears VBZ B-VP O
largely RB B-ADJP O
refractory JJ I-ADJP O
to TO B-PP O
a DT B-NP O
trial NN I-NP O
of IN B-PP O
CPAP NNP B-NP O
therapy NN I-NP O
, , O O
particularly RB B-ADVP O
in IN B-PP O
so RB B-NP O
far RB I-NP O
as IN B-SBAR O
he PRP B-NP O
demonstrates VBZ B-VP O
associated VBN I-VP O
claustrophobic JJ B-NP O
symptoms NNS I-NP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
it PRP B-NP O
's VBZ B-VP O
usage NN B-NP O
, , O O
despite IN B-PP O
relatively RB B-NP O
modest JJ I-NP O
CPAP NNS I-NP O
water NN I-NP O
pressures NNS I-NP O
( -LRB- B-VP O
6 CD B-NP O
cm NN I-NP O
) -RRB- I-NP O
. . O O
In IN B-PP O
addition NN B-NP O
, , O O
he PRP B-NP O
has VBZ B-VP O
tried VBN I-VP O
various JJ B-NP O
nasal JJ I-NP O
CPAP JJ I-NP O
face NN I-NP O
mask NN I-NP O
, , O O
including VBG B-PP O
the DT B-NP O
Mallinckrodt NNP I-NP O
" `` I-NP O
Breeze NNP I-NP O
" '' I-NP O
supportive JJ I-NP O
head NN I-NP O
gear NN I-NP O
with IN B-PP O
"nasal JJ B-NP O
pillows NNS I-NP O
" '' O O
and CC B-PP O
with IN B-PP O
limited JJ B-NP O
success NN I-NP O
. . O O
One PRP B-NP O
might MD B-VP O
consider VB I-VP O
repeating VBG I-VP O
a DT B-NP O
polysomnographic JJ I-NP O
evaluation NN I-NP O
in IN B-PP O
the DT B-NP O
future NN I-NP O
, , O O
and CC O O
if IN B-ADVP O
so RB I-ADVP O
, , O O
utilizing VBG B-VP O
a DT B-NP O
potential JJ I-NP O
trial NN I-NP O
of IN B-PP O
BIPAP NNP B-NP O
titration NN I-NP O
, , O O
which WDT B-NP O
may MD B-VP O
help VB I-VP O
to TO I-VP O
improve VB I-VP O
claustrophobic NN B-NP O
symptoms NNS I-NP O
, , O O
but CC O O
the DT B-NP O
patient NN I-NP O
will MD B-VP O
still RB I-VP O
be VB I-VP O
left VBN I-VP O
with IN B-PP O
the DT B-NP O
issues NNS I-NP O
referable JJ B-ADJP O
to TO B-PP O
"tangled JJ B-NP O
tubing NN I-NP O
at IN B-PP O
night NN B-NP O
" '' O O
and CC O O
issues NNS B-NP O
referable JJ B-ADJP O
to TO B-PP O
nasal JJ B-NP O
face NN I-NP O
mask NN I-NP O
usage NN I-NP O
, , O O
as IN B-SBAR O
noted VBN B-VP O
above IN B-PP O
. . B-NP O
3. WDT O O
Relative JJ B-NP O
difficulties NNS I-NP O
in IN B-PP O
sleep NN B-NP O
reinitiation NN I-NP O
and CC I-NP O
maintenance NN I-NP O
: : O O
The DT B-NP O
patient NN I-NP O
describes VBZ B-VP O
at IN B-NP O
least JJS I-NP O
2-4 CD I-NP O
early JJ I-NP O
morning NN I-NP O
awakenings NNS I-NP O
with IN B-PP O
difficulty NN B-NP O
in IN B-PP O
sleep NN B-NP O
reinitiation NN I-NP O
and CC I-NP O
maintenance NN I-NP O
, , O O
thereby RB B-ADVP O
compounding VBG B-VP O
his PRP$ B-NP O
current JJ I-NP O
sleep NN I-NP O
problem NN I-NP O
. . O O
While IN O O
there EX B-NP O
would MD B-VP O
logically RB I-VP O
be VB I-VP O
a DT B-NP O
relationship NN I-NP O
between IN B-PP O
his PRP$ B-NP O
current JJ I-NP O
sleep NN I-NP O
exacerbations NNS I-NP O
and CC O O
the DT B-NP O
recent JJ I-NP O
death NN I-NP O
of IN B-PP O
his PRP$ B-NP O
wife NN I-NP O
from IN B-PP O
pancreatic JJ B-NP O
cancer NN I-NP O
last JJ B-NP O
year NN I-NP O
, , O O
there EX B-NP O
may MD B-VP O
also RB I-VP O
be VB I-VP O
evidence NN B-NP O
of IN B-PP O
other JJ B-NP O
nocturnal JJ I-NP O
sleep NN I-NP O
disturbances NNS I-NP O
for IN B-PP O
which WDT B-NP O
a DT B-NP O
repeat NN I-NP O
polysomnographic JJ I-NP O
evaluation NN I-NP O
; : O O
i NN B-NP O
.e NN I-NP O
. . O O
in IN B-PP O
particular JJ B-NP O
looking VBG I-NP O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
increased VBN B-NP O
spontaneous JJ I-NP O
arousals NNS I-NP O
or CC I-NP O
limb NN I-NP O
associated VBN I-NP O
arousals NNS I-NP O
or CC O O
periodic JJ B-NP O
limb NN I-NP O
movements NNS I-NP O
of IN B-PP O
sleep NN B-NP O
may MD B-VP O
be VB I-VP O
of IN B-PP O
a DT B-NP O
special JJ I-NP O
clinical JJ I-NP O
benefit NN I-NP O
. . O O
PLAN NNP B-NP O
: : O O
1 LS B-NP O
. . O O
In IN B-PP O
the DT B-NP O
short JJ I-NP O
course NN I-NP O
, , O O
in IN B-PP O
so RB B-ADVP O
far RB I-ADVP O
as IN B-SBAR O
the DT B-NP O
patient NN I-NP O
describes VBZ B-VP O
himself PRP B-NP O
as IN B-PP O
being VBG B-VP O
exceedingly RB B-ADJP O
tired JJ I-ADJP O
, , O O
and CC O O
unable JJ B-ADJP O
to TO B-VP O
perform VB I-VP O
the DT B-NP O
routine JJ I-NP O
daily JJ I-NP O
tasks NNS I-NP O
of IN B-PP O
work NN B-NP O
and CC O O
managing VBG B-VP O
a DT B-NP O
family NN I-NP O
in IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
his PRP$ B-NP O
deceased JJ I-NP O
wife NN I-NP O
, , O O
I PRP B-NP O
have VBP B-VP O
suggested VBN I-VP O
initiation NN B-NP O
of IN B-PP O
PRN NNP B-NP O
Zolpidem NNP I-NP O
tartrate JJ I-NP O
therapy NN I-NP O
, , O O
5 CD B-NP O
mg NN I-NP O
tablets NNS I-NP O
, , O O
utilizing VBG B-VP O
one CD B-NP O
to TO I-NP O
two CD I-NP O
tablets NNS I-NP O
p.o RB B-ADVP O
. . O O
q JJ B-ADJP O
. . O O
h JJ B-NP O
.s NNS I-NP O
. . O O
PRN NN B-VP O
for IN B-PP O
difficulties NNS B-NP O
of IN B-PP O
sleep NN B-NP O
reinitiation NN I-NP O
and CC I-NP O
maintenance NN I-NP O
. . O O
2. DT B-NP O
The DT I-NP O
patient NN I-NP O
is VBZ B-VP O
advised VBN I-VP O
to TO I-VP O
take VB I-VP O
Zolpidem NNP B-NP O
tartrate NN I-NP O
therapy NN I-NP O
no RB B-ADVP O
more JJR B-NP O
than IN I-NP O
2-3 CD I-NP O
times NNS I-NP O
per IN B-PP O
week NN B-NP O
, , O O
in IN B-PP O
an DT B-NP O
effort NN I-NP O
to TO B-VP O
avoid VB I-VP O
any DT B-NP O
issues NNS I-NP O
of IN B-PP O
physiologic NN B-NP O
dependency NN I-NP O
. . O O
3. DT B-NP O
The DT I-NP O
patient NN I-NP O
was VBD B-VP O
advised VBN I-VP O
against IN B-PP O
potential JJ B-NP O
adverse JJ I-NP O
behavioral NN I-NP O
and CC O O
or CC O O
systemic JJ B-NP O
side NN I-NP O
effects NNS I-NP O
of IN B-PP O
Zolpidem NNP B-NP O
tartrate JJ I-NP O
therapy NN I-NP O
including VBG I-NP O
hypersomnolence NN I-NP O
, , O O
gastric JJ B-NP O
upset JJ I-NP O
, , I-NP O
loose JJ I-NP O
stools NNS I-NP O
, , O O
diarrhea NN B-NP O
, , O O
and CC O O
or CC O O
cardiac JJ B-NP O
palpitations NNS I-NP O
. . O O
Pending VBG B-VP O
his PRP$ B-NP O
clinical JJ I-NP O
response NN I-NP O
of IN B-PP O
his PRP$ B-NP O
Zolpidem NNP I-NP O
tartrate NN I-NP O
therapy NN I-NP O
, , O O
I PRP B-NP O
then RB B-ADVP O
might MD B-VP O
seek VB I-VP O
direct JJ B-NP O
treatment NN I-NP O
for IN B-PP O
his PRP$ B-NP O
sleep NN I-NP O
disordered VBD B-VP O
breathing VBG I-VP O
issues NNS B-NP O
which WDT B-NP O
may MD B-VP O
include VB I-VP O
a DT B-NP O
repeat NN I-NP O
sleep NN I-NP O
study NN I-NP O
with IN B-PP O
potential JJ B-NP O
trial NN I-NP O
of IN B-PP O
BIPAP NNP B-NP O
therapy NN I-NP O
( -LRB- I-NP O
in IN B-PP O
an DT B-NP O
effort NN I-NP O
to TO B-VP O
modify VB I-VP O
or CC I-VP O
attenuate VB I-VP O
claustrophobic JJ B-NP O
symptoms NNS I-NP O
) -RRB- B-VP O
. . O O
If IN B-SBAR O
he PRP B-NP O
proves VBZ B-VP O
poorly RB B-ADJP O
responsive JJ I-ADJP O
to TO B-PP O
trial NN B-NP O
of IN B-PP O
BIPAP NNP B-NP O
therapy NN I-NP O
however RB B-ADVP O
, , O O
I PRP B-NP O
might MD B-VP O
consider VB I-VP O
supplemental JJ B-NP O
O2 JJ I-NP O
therapy NN I-NP O
at IN B-PP O
night NN B-NP O
and CC O O
, , O O
with IN B-PP O
this DT B-NP O
in IN B-PP O
mind NN B-NP O
a DT B-NP O
follow VBP B-VP O
up RP B-PRT O
sleep NN B-NP O
study NN I-NP O
should MD B-VP O
have VB I-VP O
associated VBN I-VP O
end-tidal JJ B-NP O
CO2 NNP I-NP O
monitoring NN I-NP O
as RB B-ADVP O
well RB I-ADVP O
. . O O
4 LS O O
. . O O
In IN B-PP O
the DT B-NP O
meantime NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
advised VBN I-VP O
to TO I-VP O
contact VB I-VP O
the DT B-NP O
sleep NN I-NP O
disorders NNS I-NP O
clinic NN I-NP O
for IN B-PP O
any DT B-NP O
acute JJ I-NP O
sleep NN I-NP O
related VBN B-VP O
concerns NNS B-NP O
in IN B-PP O
the DT B-NP O
interim NN I-NP O
. . O O
5 CD B-NP O
. . O O
The DT B-NP O
patient NN I-NP O
may MD B-VP O
also RB I-VP O
benefit VB I-VP O
from IN B-PP O
nonpharmacologic JJ B-NP O
approaches NNS I-NP O
with IN B-PP O
regards NNS B-NP O
to TO B-VP O
sleep VB I-VP O
reinitiation NN B-NP O
such JJ B-PP O
as IN I-PP O
hypnotherapy NN B-NP O
, , O O
but CC O O
I PRP B-NP O
will MD B-VP O
hold VB I-VP O
off RP B-PRT O
on IN B-PP O
these DT B-NP O
strategies NNS I-NP O
pending VBG B-VP O
follow VB I-VP O
up RP B-PRT O
sleep NN B-NP O
disorders NNS I-NP O
clinic NN I-NP O
evaluation NN I-NP O
( -LRB- I-NP O
in IN B-PP O
approximately RB B-NP O
four CD I-NP O
months NNS I-NP O
time NN B-NP O
) -RRB- B-VP O
. . O O
Once RB B-ADVP O
again RB I-ADVP O
, , O O
thank VB B-VP O
you PRP B-NP O
again RB B-ADVP O
for IN B-PP O
allowing VBG B-VP O
me PRP B-NP O
to TO B-VP O
share VB I-VP O
in IN B-PP O
the DT B-NP O
medical JJ I-NP O
care NN I-NP O
of IN B-PP O
Mr. NNP B-NP O
Harlan NNP I-NP B-PATIENT
Valdez NNP I-NP I-PATIENT
. . O O
I PRP B-NP O
hope VBP B-VP O
this DT B-NP O
letter NN I-NP O
finds VBZ B-VP O
you PRP B-NP O
well RB B-ADVP O
. . O O
Sincerely RB B-ADVP O
yours PRP B-NP O
, , O O
Yovani NNP B-NP B-DOCTOR
Vergara NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
Sleep NN B-NP O
Clinic NNP I-NP O
Doctors NNS B-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
North NNP I-NP I-HOSPITAL
cc NN B-NP O
: : O O
Sleep VB B-VP O
Clinic NNP B-NP O
DHN . O B-HOSPITAL
DD NNP B-NP O
: : O O
09/14/2109 CD O B-DATE
DT NNP B-NP O
: : O O
09/15/2109 CD O B-DATE
TX NNP B-NP I-IDNUM
:24217 CD I-NP I-IDNUM
:1991 NN I-NP I-IDNUM
